Michael Saylor Advocates Bitcoin as Corporate Financial Strategy
- Michael Saylor compares Bitcoin to insulin for managing “corporate diabetes”.
- Companies face a 10% annual capital loss due to low-yield treasury bonds.
- Bitcoin is presented as a resilient and reliable treasury reserve asset.
- Saylor emphasizes Bitcoin’s immunity to governmental or corporate censorship.
- He warns against using cryptocurrencies like Ethereum or Solana for corporate reserves.
Michael Saylor highlights that adopting a Bitcoin standard can prevent companies from losing up to 10% of their capital annually, positioning Bitcoin as a strategic asset for financial stability.
Source (2.6)https://hodl.press/michael-saylor-bitcoin-as-insulin-for-corporate-diabetes/?rand=24434
